RxDoctor Payments Data

Emmanuel Isaac, DO

Family Medicine · Deerfield Beach, FLNPI 1467635482

Payments from drug & device makers

$1,096in general payments, 2019–2025

Across 27 payments — averaging $40.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$213
  • Medtronic$198
  • Convatec Inc.$146
  • E.r. Squibb & Sons, L.L.C.$131
  • Exact Sciences$104
  • Merck$101
  • plus $202 from 8 others

What the payments were for

  • Food & beverage$1,096100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,096 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$11,559
Medicare patients
26
Services billed
131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala12$45,815
OzempicSemaglutide37$36,130
JanuviaSitagliptin Phosphate25$27,231
Breo ElliptaFluticasone/Vilanterol13$5,712
Rosuvastatin Calcium47$1,946
Pantoprazole Sodium32$685
Losartan Potassium43$664
Atorvastatin Calcium45$579
Hydroxyzine Hcl45$549
Amlodipine Besylate66$507
Albuterol Sulfate HfaAlbuterol Sulfate19$482
Montelukast Sodium21$476
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$420
Glimepiride13$414
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$372

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$33$45,81512 claims
Novo NordiskOzempic$25$36,13037 claims
MerckJanuvia$101$27,23125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Deerfield Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →